Robert DeBenedetto
InvestorManaging Director, CCD at Abingworth
About
Robert DeBenedetto joined Abingworth in August 2024 with over 30 years of experience in the life science industry. He previously founded and led SFJ Pharmaceuticals as President and CEO, worked as a Senior Advisor to Blackstone Life Sciences, and held earlier roles at Quintiles (now IQVIA), Boston Scientific, and EY. He holds a Master's degree from Bentley University.
Invests in
Biotech
Investments
Board seats
SFJ Pharmaceuticals, Inc.
Per the firm's website.
Colleagues at Abingworth
Alex Asquith
Counsel at Abingworth
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Ankur Shah
Vice President, CCD at Abingworth
Anna Slezak
Senior Associate at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Carlos Paya
Venture Partner at Abingworth
Dayle Hogg
Operating Executive at Abingworth
Diya Malhotra
Principal at Abingworth
Frequently asked questions
- Who is Robert DeBenedetto?
- Robert DeBenedetto joined Abingworth in August 2024 with over 30 years of experience in the life science industry. He previously founded and led SFJ Pharmaceuticals as President and CEO, worked as a Senior Advisor to Blackstone Life Sciences, and held earlier roles at Quintiles (now IQVIA), Boston Scientific, and EY. He holds a Master's degree from Bentley University.
- Where does Robert DeBenedetto work?
- Robert DeBenedetto is Managing Director, CCD at Abingworth.
- What does Robert DeBenedetto invest in?
- Robert DeBenedetto invests in Biotech.
- What boards does Robert DeBenedetto sit on?
- Robert DeBenedetto holds tracked board seats at SFJ Pharmaceuticals, Inc..